Articles

FengRui 2025 Year-End Review: Staying True to First Principles, Resiliently Navigating Cycles

Yunqi Capital | Noematrix Closes Series A Funding Round

R&D iteration and commercial deployment are accelerating.

Yunqi Capital Research | Embodied Intelligence in Industrial Scenarios: In-Depth Analysis of Capabilities and Applications

Full Throttle · Yunqi Capital New Year Goods Collection Vol. 1

New Forces Keep Coming｜5Y News Monthly

The big news from last month.

CasCade Therapeutics Closes Nearly 500 Million Yuan Major Funding Round, Targeting Nuclear Receptor and GPCR Innovative Drug R&D

Dedicated to becoming a global leader in metabolic disease therapeutics.

5Y Capital Investor Notes: Agents Are a New Form of Life, and They're Hungry Today | 5Y View

The greatest investment opportunity isn't building a better Agent — it's becoming the water and air that the Agent world depends on to survive.

Linear Capital's New Year Reading List Is Now Open Source — Trading Cognitive Upgrades with You | Linear Recommend

Capturing new signals at the cross-entropy of technology and the humanities.

StarSilk Completes Multiple Strategic Funding Rounds, Deepening Focus on Commercial Aerospace and 5G/6G Satellite Internet

Solidifying leadership in 5G NTN direct-to-cell satellite baseband SoC chips.

Qu Tian: From *The Art of War* to the Mindset of Going Global | Late 2025

It was never a sprint.

A Conversation with Sam Guo: Staying Out of the Fray, but Keeping on Winning

Truck drivers, sour kiwis, counterfeit cigarettes and booze — and the legends of investing.